Fact CheckerSign in

NCT07046520Completed

Effects of HIIT on Plasma Volume and Aerobic Capacity in Obese Adolescent Girls

Effects of High-Intensity Interval Training on Plasma Volume, Muscle Damage, and Aerobic Performance in Overweight Adolescent Females

Source: ClinicalTrials.gov · Last updated 4 Jul 2025

Brief summary (registry, in English)

The goal of this clinical trial is to investigate the impact of high-intensity interval training (HIIT) program on body composition, hematological parameters, plasma volume variations (PVV), muscle damage markers, and aerobic capacity in overweight/obese adolescent girls. The main question it aims to answer is: Does HIIT reduce risk factors associated obesity diseases by modulating body composition and hematological parameters and increasing PVV? Researchers will compare HIIT (designed to the experimental group) to nontraining intervention (designed to the control group) to see if the training program works to enhance physiological health and reduce risk factors associated with obesity in this population. Participants in the experimental (HIIT group) group will: underwent HIIT at 90-105% maximal aerobic speed (MAS), three times a week. Participants in control group will : not perform any physical training and maintain their usual daily activities.

Status (registry)
Completed
Study type
Interventional
Enrollment
28 (actual)
First submitted
23 Jun 2025
Start date
9 Dec 2024
Primary completion date
28 Feb 2025
Lead sponsor
High Institute of Sports and Physical Education of Kef
Diseases
Obesity
NCT number
NCT07046520

What you commit to

  • Study type: Interventional
  • Participants enrolled: 28
  • From 9 Dec 2024 to the primary completion date, 28 Feb 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Hormone replacement therapy or therapies for obesity.
  • Restrictive diet or use of dietary supplements or engagement in any structured physical training either currently or during the previous three months.

Other illness

  • Pharmacological treatments or medical conditions that could interact with the protocol (e.g.,hypertension, diabetes, cardiac, orthopedic, neuromuscular, or neurological disorders).

Other

  • Irregular menstrual cycle.
  • Withdrawal of consent.
  • Non-compliance with study procedures.
  • Insufficient data for analysis.

Who the study is looking for

  • Females.
  • Aged between 15 and 17 years.
  • BMI greater than or equal to the 95th percentile for their age.

Age in the registry: 15 years to 17 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
High Institute of Sports and Physical Education of Kef
Coordinator of this site? Confirm its status
El KefTunisiaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.